Sarepta Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -72.7% | -72.7% | -18.6% |
| FY2021 | -45.1% | -28.1% | -13.3% |
| FY2022 | -182.7% | -36.5% | -22.5% |
| FY2023 | -62.4% | -25.6% | -16.4% |
| FY2024 | 15.4% | 8.8% | 5.9% |
| FY2025 | -62.5% | -36.2% | -21.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -72.7% | -72.7% | -18.6% |
| FY2021 | -45.1% | -28.1% | -13.3% |
| FY2022 | -182.7% | -36.5% | -22.5% |
| FY2023 | -62.4% | -25.6% | -16.4% |
| FY2024 | 15.4% | 8.8% | 5.9% |
| FY2025 | -62.5% | -36.2% | -21.3% |